Ischemic heart disease 1

Published on September 30, 2015   25 min

Other Talks in the Therapeutic Area: Cardiovascular & Metabolic

DR. VIVEK LAL: Hi, this is Dr. Vivek Lal from the King Faisal University in Saudi Arabia. I'm a pharmacologist and a medical teacher. Today, I will speak at length on Ischemic Heart Disease, or IHD, which is a major clinical problem globally.
So before we begin the discussion, let's first get acquainted with the problem and understand its epidemiological ramifications. Coronary artery disease or ischemic heart disease is a major cause of morbidity and mortality in both the developed and the developing countries. It is a cause of 17.3 million deaths worldwide, as per a study which was done in 2013 which is called the Global Burden of Disease Study. Since 1990, that has been a 41% increase in the prevalence of ischemic heart disease. And it has been observed that the lifetime risk of ischemic heart disease in men is 49% and 32% in women at 40 years of age. And it is 35% and 24% in men and women at the age of 70 years.